Ovarian Cancer The Role of Functional Imaging as an End Point in Clinical Trials

被引：2

作者：

Sala, Evis ^{[1
]}

DeSouza, Nandita ^{[2
,3
]}

Lee, Susanna I. ^{[4
]}

Atri, Mostafa ^{[5
]}

Hricak, Hedvig ^{[6
]}

机构：

[1] Addenbrookes Hosp, Dept Radiol, Cambridge CB2 0QQ, England

[2] Inst Canc Res, Surrey, England

[3] Royal Marsden Hosp, Surrey, England

[4] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA

[5] Univ Toronto, Abdominal Div, Toronto, ON M5S 1A1, Canada

[6] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2010年 / 20卷 / 06期

关键词：

Ovarian cancer; Functional imaging; Biomarker; Clinical trial; APPARENT DIFFUSION-COEFFICIENT; POSITRON-EMISSION-TOMOGRAPHY; DIAGNOSTIC ONCOLOGY GROUP; CONTRAST-ENHANCED MRI; COMPUTED-TOMOGRAPHY; PET-CT; PERITONEAL CARCINOMATOSIS; NEOADJUVANT CHEMOTHERAPY; 2ND-LOOK LAPAROTOMY; PREDICTING RESPONSE;

D O I：

10.1111/IGC.0b013e3181e0a353

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Gynaecological Cancer InterGroup conducts collaborative trials in gynecologic cancer and also aims to develop standards that can be used to strengthen all aspects of study methodology. There is an urgent need to develop more refined imaging end points that can be used as early treatment response biomarkers in ovarian cancer. Therefore, the Gynaecological Cancer InterGroup commissioned an expert position paper on the role of functional imaging as an end point in clinical trials in ovarian cancer. In this position paper, we state the limitation of current anatomical imaging methods used in clinical trials, highlight the potential of functional imaging, and provide key recommendations on the use of functional imaging as an end point in ovarian cancer clinical trials.

引用

页码：971 / 978

页数：8

共 81 条

[1] Ovarian cancer: Strategies for overcoming resistance to chemotherapy [J].

Agarwal, R ;

Kaye, SB .

NATURE REVIEWS CANCER, 2003, 3 (07) :502-516

[2] Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations [J].

不详 .

NEOPLASIA, 2009, 11 (02) :102-125

[3]

[Anonymous], 2008, PRIOR PERS MED

[4]

[Anonymous], 2009, CANC FACTS FIG 2009

[5] Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer [J].

Avril, N ;

Sassen, S ;

Schmalfeldt, B ;

Naehrig, J ;

Rutke, S ;

Weber, WA ;

Werner, M ;

Graeff, H ;

Schwaiger, M ;

Kuhn, W .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7445-7453

[6] Standards for PET Image Acquisition and Quantitative Data Analysis [J].

Boellaard, Ronald .

JOURNAL OF NUCLEAR MEDICINE, 2009, 50 :11S-20S

[7] Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm [J].

Chi, Dennis S. ;

Eisenhauer, Eric L. ;

Zivanovic, Oliver ;

Sonoda, Yukio ;

Abu-Rustum, Nadeem R. ;

Levine, Douglas A. ;

Guile, Matthew W. ;

Bristow, Robert E. ;

Aghajanian, Carol ;

Barakat, Richard R. .

GYNECOLOGIC ONCOLOGY, 2009, 114 (01) :26-31

[8] Peritoneal metastases: Detection with spiral CT in patients with ovarian cancer [J].

Coakley, FV ;

Choi, PH ;

Gougoutas, CA ;

Pothuri, B ;

Venkatraman, E ;

Chi, D ;

Bergman, A ;

Hricak, H .

RADIOLOGY, 2002, 223 (02) :495-499

[9] Apparent diffusion coefficient: Potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases [J].

Cui, Yong ;

Zhang, Xiao-Peng ;

Sun, Ying-Shi ;

Tang, Lei ;

Shen, Lin .

RADIOLOGY, 2008, 248 (03) :894-900

[10] Peritoneal carcinomatosis from colorectal or appendiceal origin:: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement [J].

De Bree, E ;

Koops, W ;

Kröger, R ;

Van Ruth, S ;

Witkamp, AJ ;

Zoetmulder, FAN .

JOURNAL OF SURGICAL ONCOLOGY, 2004, 86 (02) :64-73

← 1 2 3 4 5 6 7 8 9 →